Pharmaceutical Supply – Sodium Chloride 0.9% Injection, 500 mL

The contract pertains to the supply and delivery of FDA-compliant Sodium Chloride 0.9% Injection, USP, in 500 mL volumes, packaged in cases containing 24 units each, for a military consignee located in Jordan. The product must meet all applicable United States Pharmacopeia standards and receive full FDA approval, ensuring safety and efficacy for medical use in a military healthcare environment. Delivery is expected to comply with strict pharmaceutical logistics requirements including proper temperature control, labeling, and documentation to meet international military supply protocols. The contract is classified as a subcontract under NAICS code 325412, which corresponds to pharmaceutical and biological product manufacturing, and is managed by the Department of Defense through the Medical Supply Chain Pharm FSA. The solicitation was posted on July 23, 2026, with a response deadline of July 29, 2026, indicating a rapid procurement timeline typical of defense medical supply needs. All bids must adhere to the specifications outlined in the official solicitation accessible via the DIBBS platform, and performance is expected to fulfill the urgent requirements of the Jordan-based military recipient without delay.